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Aims: To evaluate the role of nitric oxide, reactive oxygen species (ROS), and natriuretic
peptide receptor-B activation in C-type natriuretic peptide-anti-contractile effect on
Phenylephrine-induced contraction in aorta isolated from septic rats.
Methods and Results: Cecal ligation and puncture (CLP) surgery was used to
induce sepsis in male rats. Vascular reactivity was conducted in rat aorta and
resistance mesenteric artery (RMA). Measurement of survival rate, mean arterial
pressure (MAP), plasma nitric oxide, specific protein expression, and localization were
evaluated. Septic rats had a survival rate about 37% at 4 h after the surgery,
and these rats presented hypotension compared to control-operated (Sham) rats.
Phenylephrine-induced contraction was decreased in sepsis. C-type natriuretic peptide
(CNP) induced anti-contractile effect in aortas. Plasma nitric oxide was increased in
sepsis. Nitric oxide-synthase but not natriuretic peptide receptor-B expression was
increased in septic rat aortas. C-type natriuretic peptide-anti-contractile effect was
dependent on nitric oxide-synthase, ROS, and natriuretic peptide receptor-B activation.
Natriuretic peptide receptor-C, protein kinase-CαmRNA, and basal nicotinamide adenine
dinucleotide phosphate (NADPH)-dependent ROS production were lower in septic
rats. Phenylephrine and CNP enhanced ROS production. However, stimulated ROS
production was low in sepsis.
Conclusion: CNP induced anti-contractile effect on Phenylephrine contraction in aortas
from Sham and septic rats that was dependent on nitric oxide-synthase, ROS, and
natriuretic peptide receptor-B activation.
Keywords: C-type natriuretic peptide, sepsis, natriuretic peptide receptor B, reactive oxygen species, nitric oxide,
phenylephrine-induced contraction
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INTRODUCTION
One of the most important clinical characteristics of sepsis
and septic shock is the vascular hyporesponsivity to contractile
agonists (Donaldson and Myers, 1996; Vromen et al., 1996;
Strunk et al., 2001). It represents an important condition
for patient survival. Different therapeutic strategies aimed to
improve vital organ function (Leone and Martin, 2008). The
identification of new intracellular signaling related to sepsis
progression might contribute to the development of therapeutic
strategies to reduce sepsis-associated mortality.
Sepsis cardiovascular dysfunction involves excessive nitric
oxide (NO) production (Strunk et al., 2001) by NO-synthases
(NOS) (Thomas et al., 2008). The endothelial NOS (NOS3) plays
main role on organ blood flow distribution and is related to
microvascular permeability regulation and cell interaction. Sand
et al. (2015) showed that mesenteric blood flow decreases in a
time-dependent manner and in parallel with the development
of metabolic acidosis and organ dysfunction after induction
of sepsis. Inducible NOS (NOS2) is constitutively expressed
on few quantities and its protein expression is enhanced
after inflammatory stimuli in different cells (Strunk et al.,
2001). Sustained NO production following NOS2 induction is
associated with sepsis hyporesponsivity (Donaldson and Myers,
1996; Vromen et al., 1996; Strunk et al., 2001). Furthermore,
the role of neuronal NOS (or NOS1) seems to contribute to
the hyporesponsivity of contractile adrenergic agonists in sepsis
(Nardi et al., 2014). The inhibition of soluble guanylyl cyclase
(sGC), enzyme which is the main target to NO, is able to recover
mean arterial pressure (MAP) and enhance cardiac contractility
in septic patients (Fernandes et al., 2009).
The oxidative stress is associated with impaired
vasoconstriction in sepsis (Szabó et al., 1995; Salvemini and
Cuzzocrea, 2002; Wu et al., 2004). According to Wu et al.
(2004), antioxidant treatment, before cecal ligation and puncture
(CLP) surgery to induce sepsis, increases mice survival, and
decreases hypotension, plasma NO metabolites, oxidative stress,
NOS2 mRNA, and angiotensin II (AngII) hyporesponsivity.
Abbreviations: Ana, Anantin; AngII, Angiotensin II; ANP, Atrial natriuretic
peptide; AUC, Area under the curve; BNP, Brain natriuretic peptide; cGMP,
Cyclic guanosine-monophosphate; CLP, Cecal ligation and puncture; CNP,
C-type natriuretic peptide; CO, Control; DAG, Diacylglycerol; DPI, Diphenylene
iodonium chloride; DTPA, Diethylene triaminepentaacetic acid; FI, Fluorescence
intensity; FITC, Fluorescein isothiocyanate; g.g−1, Gram of contraction per
gram of dry tissue weight; GAPDH, glyceraldehyde-3-phosphate dehydrogenase;
GK, cGMP-dependent kinase; H2O2, Hydrogen peroxide; HRP, Horseradish
peroxidase; HUVEC, Human umbilical vein endothelial cells; IL, Interleukin; IP3,
Inositol-trisphosphate; JNK, c-Jun N-terminal kinases; L-NAME, Nω-nitro-L-
arginine methyl ester hydrochloride; LPS, Lipopolysaccharide; MAP, Mean arterial
pressure; ME, Maximum effect; mmHg, Milimeters of mercury; mN.mm−1,
Milinewton per milimeter; NADPH, Nicotinamide adenine dinucleotide
phosphate; NaOH, Sodium hydroxide; NEM, N-ethylmaleimide; NO, Nitric
oxide; NOS, Nitric oxide synthase; NOx, nitrite + nitrate; Nox1, NADPH
oxidase 1; NPR, Natriuretic peptide receptor; O−2 , Superoxide anion; ONOO
−,
Peroxynitrite; PE, Phenylephrine; PEG, Polyethylene glycol; PKC, Protein kinase
C; PLC, Phospholipase C; qPCR, Quantitative polymerase chain reaction; RLU,
Relative luminescence unit; RMA, Resistance mesenteric arteries; ROS, Reactive
oxygen species; Sham, Sham-operated rats; SOD, Superoxide dismutase; pGC,
Particulate guanylyl cyclase; sGC, Soluble guanylyl cyclase; TNF, Tumor necrosis
factor; U, Units; VSM, Vascular smooth muscle.
Regarding to endothelial cells, Li et al. (2016) showed that
lipopolysaccharide (LPS) treatment of human umbilical
vein endothelial cells (HUVEC) increases oxidative stress,
malondialdehyde levels, superoxide dismutase 2 (SOD2) protein
expression and phosphorylation of c-Jun N-terminal kinases
(JNK), and decreases SOD1 expression. Moreover, Zhou et al.
(2012) observed that intravenous bolus injection of ascorbate, 30
min prior to CLP surgery or 3 h after CLP surgery, attenuated
NOS activity and prevented vascular permeability increases.
The C-type natriuretic peptide (CNP) is a member of the
natriuretic peptide family with high conserved amino acid
sequence (Inoue et al., 2003). It can be synthesized, stored,
and released from endothelial cells. CNP is present in LPS-,
cytokines-, and growth factors-stimulated endothelial cells (Suga
et al., 1993). However, CNP remains low on the plasma
concentration in healthy subjects (Stingo et al., 1992). CNP is
an endothelium-derived vasodilator agent (Suga et al., 1992),
it induces vasodilation in an endothelium-dependent manner
(Amin et al., 1996; Andrade et al., 2014) and it can hyperpolarize
plasmamembrane of vascular smoothmuscle (VSM) cell through
natriuretic peptide receptor (NPR)-C activation (Chauhan et al.,
2003; Garcha and Hughes, 2006). Natriuretic peptides, i.e., atrial
natriuretic peptide (ANP), brain natriuretic peptide (BNP), and
CNP are able to induce intravascular shedding of glycocalyx and
increase vascular permeability (Jacob et al., 2013). Furthermore,
the authors suggest that this condition might be present in the
pathophysiology of sepsis.
ANP, BNP (Piechota et al., 2009), and CNP (Hama et al.,
1994) are elevated on plasma samples from septic subjects. Until
now, three different NPR were characterized: NPR-A, NPR-B,
and NPR-C (Kone, 2001). ANP and BNP present affinity for
NPR-A, whereas CNP is the endogenous agonist for NPR-B.
Both NPR-A and NPR-B are associated with particulate guanylyl
cylclase (pGC), leading to the intracellular cyclic guanosine-
monophosphate (cGMP) formation (Rautureau et al., 2010).
ANP, BNP, and CNP have similar affinity for NPR-C, which
is associated with Gi protein, adenylyl cyclase inhibition, and
phospholipase C-β (PLC-β) activation (Matsukawa et al., 1999),
as well as activation of NOS induced by calcium increase rather
than NOS phosphorylation (Murthy et al., 1998; Costa et al.,
2007; Chen et al., 2008; Andrade et al., 2014).
In VSM cells stimulated with LPS or tumor necrosis factor-
α (TNF-α), natriuretic peptides increase nitrite formation while
the NOS inhibitor reduces CNP responses, suggesting the
involvement of NO on CNP effects (Marumo et al., 1995).
NPR-A/B antagonist infusion attenuated the hypotension in a
sepsis model (Hinder et al., 1997). According to Panayiotou
et al. (2010), knockout mice to NPR-A exposed to LPS have
low systemic hypotension, and lower levels of NO metabolites,
cGMP levels and NOS2 expression compared to wild-type
septic animals. Therefore, the contribution of natriuretic peptide
system to the vascular dysfunction seems to be evident on sepsis.
However, little is known about the role of CNP in this dysfunction
and if it could act as a modulator of α1-adrenergic vascular
contraction on animals septic vessels. The hypothesis of the
present work was that CNP induces anti-contractile effect on
phenylephrine (PE) contraction in septic vessels, which effect
Frontiers in Physiology | www.frontiersin.org 2 June 2016 | Volume 7 | Article 226
Pernomian et al. C-Type Natriuretic Peptide Anti-contractile Effect
would be dependent of NO and reactive oxygen species (ROS).
This study aimed to evaluate the contribution of intracellular NO
and ROS, and the role of activation of NPR-B in the CNP-anti-
contractile effect on PE-contraction in aortas isolated from rats
submitted to CLP surgery to induce sepsis.
METHODS
Animals
All the procedures were performed in accordance with the
standards and policies of the Ethics Committee on Animal
Care and Use of the University of São Paulo (#144/2011).
Male rats (200 g) were anesthetized with Tribromoethanol (0.25
g.Kg−1, i.p.) before cathetherization surgery on femoral artery.
On the next day, the MAP was measured for basal values
(before surgery), using pressure transducer. Then, the rats
were anesthetized with Tribromoethanol (0.25 g.Kg−1, i.p.) and
randomly submitted to CLP surgery to induce sepsis, with 12
punctures using a 16 gauge-needle on anti-mesenteric border
of the cecum (Wichterman et al., 1980; Araújo et al., 2011),
or the control group was submitted to a medial laparotomy
only (Sham). Survival and MAP were evaluated for 24 h after
surgeries. Animals were maintained on standard rat chow and
water.
Functional Studies by Vascular Reactivity
Sham and CLP rats were killed by decapitation under anesthesia
(inhaled Isoflurane) and thoracic aorta and resistance mesenteric
artery (RMA) were used to measure the isometric tension.
Vascular Reactivity Studies on Aorta
Aorta was cut into rings (4 mm) and placed between two
stainless-steel stirrups and connected to an isometric force
transducer to measure tension. Cumulative concentration-effect
curves were constructed to PE (0.1 nmol.L−1−10 µmol.L−1)
in intact endothelium rat aortas. These curves were obtained
in the absence (CO) or after 30 min incubation with CNP (10
nmol.L−1), Nω-nitro-L-arginine methyl ester hydrochloride (L-
NAME, 100 µmol.L−1), Nω-propyl-L-arginine (50 nmol.L−1),
1400 W (10 nmol.L−1), Tiron (100 µmol.L−1), polyethylene
glycol-Catalase (PEG-Catalase, 250 U.mL−1), Anantin (Ana,
0.1 µmol.L−1 or 1 µmol.L−1) alone or in the combination of
each inhibitor/antagonist and CNP. The PE potency (pD2) and
contractile maximum effect (ME) were evaluated.
Vascular Reactivity on RMA
RMA were isolated and cut into rings (2 mm) using a
dissection magnifier in cold Krebs solution for small arteries.
Only the second branch of RMA with 200–350 µm of internal
circumference were used. A tungsten wire (40 µm) was passed
into the vessel and tied in myograph to resistance vessels
and another was connected to isometric force transducer.
Cumulative concentration-effect curves were constructed to PE
(0.1 nmol.L−1−100 µmol.L−1) in intact endothelium RMA in
the absence or in the presence of CNP (10 nmol.L−1, 30 min).
The area under the curve (AUC) of PE contraction was evaluated.
Measurement of Plasma NO Metabolites
Cardiac blood samples were collected from Sham or CLP rats
in heparin-containing tubes. Plasma aliquots of Sham or CLP
rats were analyzed for their nitrite content using an ozone-based
reductive chemiluminescence assay (Pinheiro et al., 2012). The
plasma NOx concentration was determined by using the Griess
reaction (Pinheiro et al., 2012).
Western Blotting Analysis
Protein expression of NOS2, NOS3, NPR-B, or Nox1 were
analyzed in Sham or CLP rat aorta homogenate.Membranes were
incubated with mouse primary antibody anti-NOS2 (1:2500),
or anti-NOS3 (1:2500), and rabbit primary antibody anti-NPR-
B (1:5000), or anti-Nox1 (1:2000), overnight at 4◦C. Then,
membranes were incubated with a HRP-conjugated goat anti-
rabbit (1:5000) or goat anti-mouse secondary antibody (1:5000)
for 60 min at room temperature. Protein bands were visualized
by means of chemiluminescence. Protein expression levels were
normalized by mouse anti-β-actin (1:2000).
Confocal Microscopy Analysis
Aorta was isolated from Sham or CLP rats and frozen on
cryoprotection liquid. Sheets were prepared with 10 µm of
thickness and immunofluorescence was performed to evaluate
endogenous CNP (1:100) or NPR-C (1:100) expression. The
secondary antibody mouse anti-goat Alexafluor 647 (1:1000)
or sheep anti-rabbit Alexafluor 647 (1:1000) was incubated
for 1 h, at room temperature. Fluoroshield R© with DAPI was
applied overnight at 4◦C. Images were acquired using confocal
microscopy.
Lucigenin Chemiluminescence Analysis
Vascular nicotinamide adenine dinucleotide phosphate
(NADPH)-dependent ROS production was assessed in intact-
endothelium aorta from Sham or CLP rats, previously stimulated
with PE (0.1 µmol.L−1) in the absence or in the presence of CNP
(10 nmol.L−1, 30min) or not stimulated (basal). After that, aortas
were collected and frozen on liquid nitrogen. The luminescence
was measured using Single Tube Luminometer Berthold FB12,
at 37◦C. Data were presented as relative luminescence units
(RLU).mg−1.min−1.
Quantitative Polymerase Chain Reaction
(qPCR) Analysis
Total ribonucleic acid (RNA) was extracted from aorta
homogenates isolated from Sham or CLP rats with TRIzol R©
reagent according to manufacturer’s instruction. The cDNA
was synthesized with 1 µg of RNA using anchored random
hexadeoxynucleotide in the reaction conditions for transcriptor
First-strand cDNA Synthesis Kit. qPCR was performed using
SYBR R© FAST qPCR kit Master Mix Universal with 50
nmol.L−1 of primers for PKCα (protein kinase-Cα) or GAPDH
(glyceraldehyde-3-phosphate dehydrogenase). The samples were
incubated for 2 min at 50◦C and 10 min at 95◦C followed by 40
cycles at 95◦C for 15 s and 60◦C for 1 min.
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Drugs and Solutions
Drugs and solutions are presented on Supplemental Material.
Statistical Analysis
Results are presented as mean ± S.E.M. Each experimental n
represents samples isolated from different animals. Comparisons
between groups were conducted by the Student’s t-test, One-
way analysis of variance followed by Newman-Keuls, or Two-
way analysis of variance using Bonferroni correction for multiple
comparisons, as appropriate. The level of statistical significance
was defined as P < 0.05.
RESULTS
Survival and Mean Arterial Pressure
Analysis
Sham rats survival rate was 100% at 24 h after surgery (n = 20).
CLP rats had lower survival rate than Sham, and 4 h after the
CLP surgery it was 37% of survival, reaching no longer than 2%
of survival at 24 h (n= 30) (Figure 1). Basal MAP was similar in
both groups (Sham: 96.7 ± 0.6 mmHg, n = 6; CLP: 96.1 ± 0.4
mmHg, n= 6). Four hours after the surgeries, MAP decreased in
both groups which values were lower on CLP (51.4 ±0.9 mmHg,
n= 6) than in Sham rats (86.2± 0.3 mmHg, n= 6) (Figure 1).
PE Induced Contraction and CNP Induced
Anti-contractile Effect in Aorta but Not in
RMA
The ME and potency (pD2) to PE were lower on CLP (ME:
753 ± 47 g.g−1, pD2: 6.74 ± 0.14, n = 11) than in Sham aortas
(ME: 1232 ± 30 g.g−1, pD2: 7.32 ± 0.10, n = 11) (Figure 1).
Similarly, in RMA, PE-induced contraction was lower in CLP
(4.73 ± 0.52 mN.mm−1; n = 7) than in Sham (9.68 ± 1.30
mN.mm−1; n= 6). The AUC of PE-induced contraction on RMA
was also lower in CLP (9.55± 0.86) than in Sham (24.27± 2.75).
CNP induced anti-contractile effect in aortas but not in RMA
(Figure 1). CNP reduced the PE-induced contraction in Sham
aortas (ME: 877 ± 25 g.g−1; pD2: 6.68 ± 0.10; n = 8). However,
only ME was decreased by CNP in CLP aortas (ME: 365 ± 74
g.g−1). CNP anti-contractile effect was higher in CLP than Sham
aortas.
NPR-C was Decreased in CLP Compared
to Sham Aortas
As shown in the photomicrographs (Figure 2) and in the
measurement of fluorescence intensity (FI) emitted by anti-NPR-
C antibody, the NPR-C expression was lower in CLP (4.35± 0.46
U, n= 6) compared to Sham aortas (7.81± 0.80 U, n= 6).
Plasma NO and Protein Expression of
NOS3 and NOS2 were Increased, and
NPR-B was Not Changed in CLP Aortas
NOS3 protein expression in CLP aorta was greater (0.20 ± 0.02
U, n = 4) than in Sham aorta (0.10 ± 0.01, n = 4) (Figure 3).
Similarly, NOS2 protein expression in CLP aorta was higher (0.06
± 0.002 U, n = 4) than in Sham aorta (0.03 ± 0.001 U, n = 4).
However, NPR-B protein expression was not different between
Sham (0.79 ± 0.07 U, n = 4) and CLP (0.92 ± 0.06 U, n = 6).
Plasma NOmetabolites such as nitrite and nitrate were higher on
CLP (nitrite: 4.16± 0.79 µmol.L−1, n= 4; nitrate: 69.12± 10.58
µmol.L−1, n = 7) than in Sham (nitrite: 0.69 ± 0.09 µmol.L−1,
n= 4; nitrate: 21.97± 2.38 µmol.L−1, n= 7) rats.
NPR-C was Lower and NPR-B was Not
Changed in CLP in Relation to Sham Aortas
NPR-B protein expression was not different between Sham
(0.79 ± 0.07 U, n = 4) and CLP (0.92 ± 0.06 U, n = 6), whereas
NPR-C expression was lower in CLP (4.35 ± 0.46 U, n = 6)
aortas as compared to Sham (7.81 ± 0.80 U, n = 6), as shown
in Figure 3.
CNP-Induced Anti-contractile Effect was
Dependent on NOS Activity in Rat Aortas
PE-induced contraction was increased by the non-selective
inhibition of NOS with L-NAME in Sham (2097± 97 g.g−1, n=
11) and CLP (1365 ± 116 g.g−1, n = 12) aortas. But it was still
lower in CLP aortas (Figure 4). However, pD2 value increased
in CLP aortas (7.30 ± 0.09). CNP-anti-contractile effect on PE-
induced contraction was reversed by L-NAME in both groups
(Sham: 1876 ± 83 g.g−1, n = 11; CLP: 1936 ± 82 g.g−1, n = 12).
L-NAME and CNP increased pD2 values in Sham (7.58 ± 0.16)
and in CLP (7.10± 0.28) aortas.
NOS1 and NOS2 Also Contributes to
CNP-Induced Anti-contractile Effect in Rat
Aortas
The selective NOS1 inhibitor Nω-propyl did not modify the
potency to PE in Sham (7.20 ± 0.10, n = 8) or CLP (7.05 ±
0.20, n= 7) aortas (Figure 5). This inhibitor increased ME to PE
only in CLP aortas (1109 ± 79 g.g−1), whereas this contraction
remained unchanged in Sham (1349 ± 53 g.g−1). CNP-anti-
contractile effect on PE-induced contraction was reversed by
Nω-propyl in Sham (1342 ± 67 g.g−1, n = 9) or CLP (1060
± 126 g.g−1, n = 5) aortas (Figure 5). PE-induced maximum
contraction in CLP (1060 ± 126 g.g−1, n = 5) was lower than in
Sham (1342 ± 67 g.g−1) aortas in the presence of CNP and Nω-
propyl. In addition, CNP-anti-contractile effect on PE potency
was reversed in Sham (7.08 ± 0.09) and it was not modified in
CLP (6.71± 0.21) aortas.
The selective NOS2 inhibitor 1400W, increased PE pD2 value
in CLP (8.04± 0.34) and theME to PE in Sham (1427± 65 g.g−1,
n= 7) and CLP (954± 52 g.g−1, n= 7), which effect was lower in
CLP than in Sham aortas (Figure 5). The double exposure CNP
and 1400 W increased PE potency in Sham (7.19 ± 0.15, n = 8)
and CLP aortas (7.63 ± 0.34, n = 6). The ME to PE was greater
in CLP (789 ± 86 g.g−1) after the double exposure to CNP and
1400 W, but not in Sham aortas (941± 57 g.g−1).
CNP-Induced Anti-contractile Effect was
Dependent on ROS in Rat Aortas
The superoxide (O−2 ) scavenger Tiron reduced the potency to
PE in Sham (6.70 ± 0.15) but not in CLP (6.69 ± 0.20) aortas
(Figure 6). However, ME to PE was enhanced on CLP (1034 ±
70 g.g−1) aortas. Moreover, CNP-anti-contractile effect on PE
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FIGURE 1 | Percentage of survival analysis (A) of control-operated (Sham n = 20) and CLP (n = 30) rats. Mean arterial pressure (B) (MAP, mmHg) before (0
h) or after (from 1 to 4 h) surgeries in Sham (n = 6) or CLP (n = 6) rats. Cumulative concentration-effect curves to phenylephrine (PE) in the absence or in the presence
of CNP (10 nmol.L−1; Sham n = 8; CLP n = 8) in aorta (C) or resistance mesenteric artery (RMA, Sham n = 6; CLP n = 7) (D) with endothelium, from Sham or CLP
rats. Data are represented as mean ± S.E.M. In (B): *different from 0 h; #different from Sham respective time; adifferent from CLP 1, 2, or 3 h. In (C): *different from
Sham CO; #different from CLP CO; adifferent from Sham CNP. In (D): *different from Sham CO; **different from Sham CNP. Each experimental n represents samples
isolated from different animals. Two-way Anova, Bonferroni correction to evaluate interaction factor; One-way Anova, pos-hoc Newman-Keuls to three or more
comparisons (P < 0.05).
FIGURE 2 | NPR-C staining in vascular layers in Sham or CLP rat aortas. Photomicrograph of immunofluorescence of NPR-C staining in Sham (n = 6) or CLP
(n = 6) rat aortas. DIC represents dichroic contrast phase, DAPI represents nuclei staining, α-actin from α-actin smooth muscle-FITC staining. Bar represents 50 µm.
L, M, and Adv represent lumen, media layer, and adventitia, respectively. Each experimental n represents samples isolated from different animals.
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FIGURE 3 | Protein expression of NOS3 (A, Sham n = 4; CLP n = 4), NOS2 (B, Sham n = 4; CLP n = 4) and NPR-B (C, Sham n = 4; CLP n = 6) on aorta
homogenate of Sham or CLP rats. Measurement (D) of fluorescence intensity (FI) emitted by anti-NPR-C antibody in Sham (n = 6) or CLP (n = 6) rat aortas.
Measurement of plasma nitrite (E, Sham n = 4; CLP n = 4) and nitrate (F, Sham n = 7; CLP n = 7). Western blotting data were normalized by β-actin, and presented
as mean ± S.E.M. *different from Sham. Each experimental n represents samples isolated from different animals. Two-way Anova, Bonferroni correction to evaluate
interaction factor; One-way Anova, pos-hoc Newman-Keuls to three or more comparisons; Student t-test to compare two different groups (P < 0.05).
FIGURE 4 | Cumulative concentration-effect curves to phenylephrine (PE) in the absence (CO) or presence of CNP (10 nmol.L−1); non-selective
NOS-inhibitor L-NAME (100 µmol.L−1) or CNP; and L-NAME in Sham (A) (n = 11) or CLP rat aorta (B) (n = 12). pD2 values (C) of PE curves of Sham or CLP
rat aorta. Maximum effect values (D) (g.g−1) of PE curves of Sham or CLP rat aorta. Data are presented as mean ± S.E.M. *different from Sham CO; #different from
CLP CO; adifferent from Sham CNP; cdifferent from CLP CNP. Each experimental n represents samples isolated from different animals. Two-way Anova, Bonferroni
correction to evaluate interaction factor; One-way Anova, pos-hoc Newman-Keuls to three or more comparisons (P < 0.05).
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FIGURE 5 | Cumulative concentration-effect curves to phenylephrine (PE) in the absence (CO) or presence of CNP (10 nmol.L−1); selective
NOS1-inhibitor Nω-propyl-L-arginine (Nω-propyl, 50 nmol.L−1) or CNP + Nω-propyl in Sham (A) (n = 9) or CLP rat aorta (B) (n = 5). Cumulative
concentration-effect curves to PE in the absence (CO) or presence of CNP (10 nmol.L−1 ); selective NOS2-inhibitor 1400 W (100 nmol.L−1 ) or CNP + 1400 W in
Sham (C) (n = 8) or CLP rat aorta (D) (n = 6). Data are presented as mean ± S.E.M. *different from Sham CO; #different from CLP CO; adifferent from Sham CNP;
bdifferent from Sham + 1400 W; cdifferent from CLP CNP. Each experimental n represents samples isolated from different animals. Two-way Anova, Bonferroni
correction to evaluate interaction factor; One-way Anova, pos-hoc Newman-Keuls to three or more comparisons (P < 0.05).
contraction was reversed by Tiron on pD2 values (Sham: 7.18 ±
0.10, n = 6; CLP: 7.01 ± 0.13, n = 13) and ME (Sham: 1822 ±
101 g.g−1, n = 6; CLP: 1328 ± 104 g.g−1, n = 13). Although ME
to PE in CLP aortas in the presence of CNP and Tiron induced a
greater value compared to CNP alone, this value remained lower
than that one on Sham aortas.
The intracellular breakdown of hydrogen peroxide (H2O2)
with PEG-Catalase did not change the contractile response to
PE in both groups (Figure 6). However, the presence of PEG-
Catalase and CNP reversed CNP-anti-contractile effect on PE
potency (Sham: 7.07 ± 0.10, n = 5; CLP: 7.20 ± 0.25, n = 11)
and ME (Sham: 1199 ± 60 g.g−1, n = 5; CLP: 970 ± 80 g.g−1, n
= 11).
CNP-Induced Anti-Contractile Effect was
Dependent on NPR-B Activation and PE
Contraction was Modulated by NPR-B in
Rat Aortas
The non-selective NPR-A/B antagonist Anantin (0.1 µmol.L−1)
did not modify the PE pD2 values (Sham: 7.23± 0.23, n= 8; CLP:
7.05 ± 0.19, n = 13). However, it increased ME to PE in CLP
(1093 ± 107 g.g−1) but not in Sham (1198 ± 114 g.g−1) aorta
(Figure 7). CNP-anti-contractile effect was reversed in Sham and
CLP (pD2: Sham 7.50 ± 0.10; CLP: 7.35 ± 0.30; ME: Sham 1345
± 115 g.g−1, n = 8; CLP: 891 ± 86 g.g−1, n = 13) aortas.
When Anantin was used at the concentration of 1 µmol.L−1, PE-
induced contraction was potentiated in both groups (Sham: 8.49
± 0.30, n = 5; CLP: 8.06 ± 0.80, n = 11), but it did not change
ME to PE. In addition, the PE pD2 values in the presence of 1
µmol.L−1Anantin were greater than the values observed with 0.1
µmol.L−1Anantin in Sham.
Endogenous Expression of CNP was
Lower in Endothelium and Higher in VSM
Layer in CLP Than in Sham Rat Aortas
The endothelial expression of endogenous CNP, as shown in the
photomicrographs (Figure 8) and the measurement of FI of anti-
CNP antibody (Figure 9), was lower in CLP (6.50 ± 0.66 U, n
= 6) than in Sham aortas (9.78 ± 0.50 U, n = 4). However,
CNP expression on VSM was higher in CLP (9.72 ± 0.60 U, n
= 6) compared to Sham aortas (7.32 ± 0.11 U, n = 4). It was
not different in the adventitia isolated from Sham (13.35 ± 1.00
U, n = 4) and CLP aortas (15.02 ± 1.20 U, n = 6). It can be
noted that endogenous CNP is higher in the adventitia than in
the endothelium which is higher than in the VSM in Sham. CNP
is higher in adventitia than in the VSM that is higher than in the
endothelium in CLP aortas.
PE and CNP Enhanced NADPH-Dependent
ROS Production
Nox1 expression was higher in CLP (1.61 ± 0.17 U, n = 4)
than in Sham aortas (0.73 ± 0.08 U, n = 4). Basal NADPH-
dependent ROS production was lower in CLP (36.95 ± 3.27
RLU.mg−1.min−1, n = 3) than in Sham aortas (204.07 ± 20.61
RLU.mg−1.min−1, n= 5). PE increasedNADPH-dependent ROS
production in Sham (303.69 ± 30.78 RLU.mg−1.min−1, n = 8)
and CLP aortas (145.66 ± 14.05 RLU.mg−1.min−1, n = 5). CNP
and PE further increased NADPH-dependent ROS production
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FIGURE 6 | Cumulative concentration-effect curves to phenylephrine (PE) in the absence (CO) or presence of CNP (10 nmol.L−1); O−
2
scavenger Tiron
(100 µmol.L−1) or CNP + Tiron in Sham (A) (n = 6) or CLP rat aorta (B) (n = 13). Cumulative concentration-effect curves to PE in the absence (CO) or presence
of CNP (10 nmol.L−1 ); intracellular H2O2 breakdown agent PEG-catalase (250 U.mL
−1) or CNP + PEG-catalase in Sham (C) (n = 5) or CLP rat aorta (D) (n = 11).
Data are presented as mean ± S.E.M. *different from Sham CO; #different from CLP CO; adifferent from Sham CNP; bdifferent from Sham Tiron; cdifferent from CLP
CNP. Each experimental n represents samples isolated from different animals. Two-way Anova, Bonferroni correction to evaluate interaction factor; One-way Anova,
pos-hoc Newman-Keuls to three or more comparisons (P < 0.05).
FIGURE 7 | Cumulative concentration-effect curves to phenylephrine (PE) in the absence (CO) or presence of CNP (10 nmol.L−1); NPR-A/B antagonist
Anantin (Ana) in lower concentration (0.1 µmol.L−1) or CNP + Ana in Sham (A) (n = 8) or CLP rat aorta (B) (n = 13). Cumulative concentration-effect curves
to PE in absence or in the presence of Ana in higher concentration (1 µmol.L−1 ) in Sham (n = 5) or CLP rat aorta (n = 11) (C). Data are presented as mean ± S.E.M.
*different from Sham CO; #different from CLP CO; adifferent from Sham CNP; cdifferent from CLP CNP; edifferent from Sham Ana. Each experimental n represents
samples isolated from different animals. Two-way Anova, Bonferroni correction to evaluate interaction factor; One-way Anova, pos-hoc Newman-Keuls to three or
more comparisons (P < 0.05).
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FIGURE 8 | Endogenous CNP staining in vascular layers. Photomicrograph of immunofluorescence of CNP staining in Sham (n = 4) or CLP (n = 6) rat aortas.
DIC represents dichroic contrast phase, DAPI represents nuclei staining, α-actin from α-actin smooth muscle-FITC staining. Bar represents 50 µm. L, M, and Adv
represent lumen, media layer, and adventitia, respectively. Each experimental n represents samples isolated from different animals.
in Sham (690.34 ± 60.05 RLU.mg−1.min−1, n = 6) and CLP
rat aortas (382.78 ± 32.45 RLU.mg−1.min−1, n = 5). However,
all the values obtained in CLP were lower than in Sham. The
non-selective flavoproteins inhibitor DPI, which was used as a
negative control, inhibited the basal NADPH-dependent ROS
production in Sham rat aorta (−32.44 ± 2.91 RLU.mg−1.min−1,
n= 3) (Figure 9).
PKCα mRNA Expression was Lower in CLP
Than in Sham Rat Aortas
The relative PKCα mRNA expression (Figure 9) was lower in
CLP (0.43± 0.13, n= 4) than in Sham (1.55± 0.31, n= 4) aortas.
DISCUSSION
The main findings of this work were: (i) CNP induced anti-
contractile effect on PE contraction in rat aortas but not in rat
RMA, (ii) this CNP anti-contractile effect was dependent on NOS
activity, ROS production and NPR-B activation in Sham and CLP
aortas, (iii) endogenous CNP was reduced on endothelium and
increased on the VSM cells in CLP aortas, (iv) NPR-C expression
was low on VSM layer of CLP aortas, (v) basal NPR-B activity
was able to modulate PE-induced vasoconstriction, and (vi) basal
NADPH-dependent ROS production was low in CLP aortas, and
PE and CNP increased ROS production. It is the first report that
CNP can modulate PE contraction, which effect was higher in
CLP than Sham aortas.
CLP experimental sepsis model represents clinical conditions
observed on patients with intestinal puncture, developing severe
sepsis within few hours or some days (Lundblad et al., 1995).
Moreover, it was observed that CLP group had a pronounced
systemic hypotension and low survival rate, corroborating with
findings from Tyml et al. (1998), Liaw et al. (2005), and Tsao
et al. (2010). However, we have shown that Sham rats presented
lower hypotensive effect than CLP group. According to Jong et al.
(2002) general anesthetics can change cardiovascular parameters.
Therefore, in our study, the decreased MAP observed on Sham
rats could be due to tribromoethanol effect. Besides systemic
hypotension showed on CLP rats, it was noted that PE-induced
contraction on aorta and RMA was lower in CLP than in Sham
rats.
In accordance to Vromen et al. (1996) and Wang et al.
(2004), in CLP rat aortas there is low vasoconstriction induced
by norepinephrine. Silva-Santos et al. (2002) noted LPS-exposure
of aortas during 12 h, at isolated organ bath, reduced contraction
to PE. Usually, such reduced contraction to different agonists
have been associated with larger NO production by NOS1 and/or
NOS2 (Vromen et al., 1996; Silva-Santos et al., 2002; Wang
et al., 2004; Enkhbaatar et al., 2009; Tsao et al., 2010; Nardi
et al., 2014), oxidative stress (Tsao et al., 2010), and greater
inflammatory mediators production (Panayiotou et al., 2010).
Enkhbaatar et al. (2009) showed that specific NOS1 inhibitor,
called as ZK234238, attenuated hypotension and the fall in
systemic vascular resistance, inhibited the increase in plasma
nitrate/nitrite, and attenuated inflammatory markers such as
myeloperoxidase activity, IL (interleukin)-6 mRNA, and reactive
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FIGURE 9 | Measurement of FI emitted by anti-CNP antibody (A) in Sham (n = 4) or CLP (n = 6) rat aortas. Protein expression of Nox1 (B) and
NADPH-dependent reactive oxygen species (ROS) production (C) in aorta homogenate from Sham (n = 4) or CLP (n = 4) rats. ROS production (relative luminescence
units.mg−1.min−1 ) was evaluated in the absence (basal, Sham n = 5; CLP n = 3) or in the presence of PE (10 µmol.L−1, Sham n = 8; CLP n = 5) or CNP (10
nmol.L−1 ) + PE (10 µmol.L−1, Sham n = 6; CLP n = 5). Negative control was evaluated in the presence of non-selective inhibitor of flavoproteins DPI (10 µmol.L−1,
n = 3) in Sham aorta. Relative PKCα mRNA expression (D) in aorta homogenate from Sham (n = 4) or CLP (n = 4) rats. Western blotting data were normalized by
β-actin. Quantitative PCR analysis was normalized by GAPDH (glyceraldehyde-3-phosphate dehydrogenase) mRNA expression. Data are presented as mean ±
S.E.M. In (B): *different from Sham endothelium; #different from CLP endothelium; **different from VSM from respective groups. In (C): *different from Sham. In (D):
*different from Sham basal; #different from CLP basal; adifferent from Sham DPI; **different from Sham PE; ##different from CLP PE; cdifferent from Sham PE CNP.
In (E): *different from Sham. Each experimental n represents samples isolated from different animals. Two-way Anova, Bonferroni correction to evaluate interaction
factor; One-way Anova, pos-hoc Newman-Keuls to three or more comparisons; Student t-test to compare two different groups (P < 0.05).
nitrogen species. Furthermore, Nardi et al. (2014) demonstrated
that the treatment with 7-nitroindazole, another NOS1 inhibitor,
reverted the hyporesponsivity to PE and norepinephrine, and
reduced the production of cGMP stimulated by PE in CLP rat
aortas. Our results are in agreement with the others and it was
noted raise on plasma NO levels, as nitrite and nitrate, and
raise on protein expression of NOS2 and NOS3 in CLP rat
aortas. Moreover, the non-selective NOS inhibitor L-NAME, or
the selective NOS1 inhibitor Nω-propyl, or the selective NOS2
inhibitor 1400 W, increased PE contraction in both groups; but
PE-induced maximum contraction was still lower in CLP aortas,
suggesting additional mechanisms which are responsible for PE
hyporresponsivity.
CNP-induced anti-contractile effect was greater in CLP than
in Sham aortas. However, we did not observe CNP-induced
modulation of PE contraction in RMA from both groups, using
a single concentration of CNP in these studies. Villar et al.
(2007) showed CNP-induced relaxation in RMA isolated from
rats that was dependent on NPR-C activation. Besides, this group
demonstrated all the three NPRs in rat aorta and RMA. We
cannot exclude the possibility that higher CNP concentration
could induce the anti-contractile effect on these resistance vessels,
since the contraction elicited by PE needed higher concentration
in RMA than in aorta. Since this CNP anti-contractile effect
was observed on aortas at low concentration (10 nmol.L−1),
we decided to continue to investigate this vessel. CNP anti-
contractile effect was completely reversed by NOS inhibitors
showing CNP could activate NOS and NO production could
be responsible for CNP anti-contractile effect in aortas. In
the same way, Murthy et al. (1998) had demonstrated that a
selective agonist of NPR-C, called cANP(4-23), can increase
NOS activity via Gi protein and calcium influx. Costa et al.
(2007) reported that CNP increased NOS activity in aorta
homogenate and our research group (Andrade et al., 2014)
has described endothelium-dependent relaxation induced by
CNP in rat aortas that seems to lead to NPR-C activation,
but with no alteration in phosphorylation status of Ser1177
of NOS3. As described by Anand-Srivastava et al. (1996), the
activation of cytosolic domain of NPR-C leads to adenylyl cyclase
inhibition via Pertussis toxin sensitive-G protein. Furthermore,
Anand-Srivastava (2005) reviewed NPR-C intracellular signaling
with inositol-trisphosphate (IP3) and diacylglycerol (DAG)
formation, calcium mobilization, potassium channel, NOS, and
PKC activation.
Although Nox1 protein expression was higher in CLP aortas,
the basal activity of NADPH-dependent ROS production was
low in CLP aortas, suggesting another source of ROS in CLP
aortas. Moreover, Brandes et al. (1999) determined after LPS
stimulus, that there are increased NADPH oxidase and xanthine
oxidase expression in rat aortas, leading to O−2 , H2O2 production
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and after reaction with NO to form peroxynitrite (ONOO−).
Since NADPH oxidase and xanthine oxidase produce O−2 and
H2O2, these results suggest the contribution of O
−
2 to the
contractile effect to PE in Sham and CLP rat aortas. However,
when intracellular H2O2 was removed, there were no changes
on PE-induced contraction in both groups. It is possible that
ROS production in VSM cells could compensate the removal of
endothelial ROS on PE-induced contraction.
NADPH-dependent ROS production was increased after PE
alone or CNP and PE stimuli, suggesting that CNP can positively
modulate ROS production in rat aortas. In relation to the CNP
anti-contractile effect in rat aortas, it seems dependent on H2O2,
possibly through O−2 dismutation by SOD. As presented by
Anand-Srivastava (2005), CNP could stimulate PKC which in
turn activates NADPH oxidase (Brandes et al., 2014). Thus,
NADPH-dependent ROS production increased by CNP and
PE could be due to NPR-C activation dependent on PKC.
Jao et al. (2001) reported low protein expression of PKCα in
rat model of sepsis. The reduced effect of PE or CNP and
PE on NADPH-dependent ROS production could be due to
reduced PKC expression and/or PKC deficient activity in CLP
aortas. In fact, PKCα mRNA expression was lower in CLP
aortas compared to Sham. Furthermore, protein expression of
NPR-C on VSM cells from CLP aortas was lower compared
to Sham. It might suggest a reduction on protein expression
or activity of the NPR-C-PKCα-NADPH oxidase axis in CLP
aortas.
Weber et al. (1991) identified Anantin as the first competitive
antagonist of NPR associated with cGMP formation, i.e., NPR-
A and NPR-B receptors. Then, Anantin has been used as
non-selective NPR-A/B antagonist. As CNP is the endogenous
agonist of NPR-B (Koller and Goeddel, 1992) and has low
affinity for NPR-A, Anantin could be considered a NPR-B
antagonist for CNP effects. We demonstrated that CNP anti-
contractile effect was dependent on NPR-B activation, since
Anantin reversed this effect. Madhani et al. (2003) showed that
CNP relaxation was inhibited by NPR-B antagonist in mice
aortas. Rautureau et al. (2010) reported that CNP increased
cGMP production independently of sGC in endothelial cells
that was accompanied by NO production. Simon et al. (2009)
showed CNP hyperpolarizes the endothelial cell membrane in
a cGMP-dependent protein kinase (GK) manner. Activation
of NPR-B by CNP was evident in Sham and CLP aortas.
However, basal NPR-B activity without exogenous CNP was
enough to modulate PE-induced vasoconstriction. Anantin at
low concentration was able to increase PE maximum contraction
only in CLP aortas. The greater effect of Anantin on high
concentration suggests an important contribution of endogenous
CNP for regulation of vascular tone. Besides, protein expression
of NPR-B was not altered in aortas from Sham and CLP
rats.
According to Hinder et al. (1997) and Stubbe et al. (2004)
described that NPR-A/B antagonist preventing hypotension due
to sepsis. This is the first mention that endogenous CNP or NPR-
B intrinsic activity can contribute to modulation of vascular tone
in aortas from Sham and CLP rats. Moreover, endogenous CNP
production can be stimulated by several factors, such as LPS,
TNF-α, IL-1α, and IL-1β, acetylcholine and bradykinin (Suga
et al., 1993; Anand-Srivastava, 2005). Sepsis is a condition in
which plasma levels of CNP are high (Hama et al., 1994). We
demonstrated that endogenous CNP on vascular endothelium
was lower in CLP than in Sham aortas. However, the peptide
expression on VSM cells was greater in CLP than Sham aortas.
It suggests a possible release of CNP from the endothelium to
VSM in CLP aortas. Although the protein expression of NPR-B
was similar in both groups, NPR-B activity might be different in
CLP aortas.
Our results showed for the first time the CNP induced anti-
contractile effect on PE-induced contraction that was greater
in CLP than Sham aortas. This effect is dependent on NOS
activity, ROS production and NPR-B activation. O−2 and H2O2
production seems to be part of the same signaling pathway, and
PE alone or CNP and PE increase ROS production. In CLP
aortas, CNP could be released from the endothelial to VSM cells.
NPR-B intrinsic activity or endogenous CNP could modulate
the vascular tone. Furthermore, the lower protein expression of
NPR-C on VSM cells of CLP aortas and lower relative PKCα
mRNA expression could contribute to the reduction of CNP-
induced NADPH-dependent ROS production in CLP aortas.
If the activation of NOS and NPR-B belongs to a common
intracellular signaling remains to be investigated. Moreover,
it is evident the contribution of CNP system on vascular
hyporeactivity to α1-adrenergic activation in CLP aorta, and it
might represents a potential target for future pharmacological
studies.
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